<DOC>
	<DOCNO>NCT00102856</DOCNO>
	<brief_summary>The purpose study determine whether rivastigmine pramipexol effective boosting semantic language acquisition healthy subject .</brief_summary>
	<brief_title>Neuromodulation Language Acquisition ( Stage Ib )</brief_title>
	<detailed_description>Our prior work show d-amphetamine dopamine precursor levodopa markedly improve word learn success healthy subject . In randomized , placebo-controlled , double-blind clinical trial , probe whether selective d2/d3 dopamine agonist ( pramipexole ) cholinergic neuromodulation ( rivastigmine ) , titration period five day , yield learn enhancement comparable use levodopa healthy subject . The expected scientific result strengthen basis transfer neuromodulatory intervention laboratory stroke patient language dysfunction .</detailed_description>
	<mesh_term>Pramipexole</mesh_term>
	<mesh_term>Rivastigmine</mesh_term>
	<criteria>Healthy subject 2035 year old Right handedness Left language dominance ( assessed functional transcranial Doppler ultrasonography [ fTCD ] ) Neurological/psychiatric/metabolic/cardiac disorder Asthma Known allergic reaction one experimental drug Other drug affect central nervous system Leisure drug ingestion past 4 week ( urine test ) Smoking cessation past 2 week &gt; 6 cup coffee energy drink per day &gt; 10 cigarette per day &gt; 50 gram alcohol per day</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>35 Years</maximum_age>
	<verification_date>September 2006</verification_date>
	<keyword>language acquisition</keyword>
	<keyword>plasticity</keyword>
	<keyword>stroke recovery</keyword>
	<keyword>associative learning</keyword>
</DOC>